| Name | Title | Contact Details |
|---|
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as ringing in the ears.
Orametrix is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
All Med Medical Supply is a Westland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
Innovative spine and medical technology company Camber Spine is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology. Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, we are making quantum leaps in the spinal fusion market. Our patented OLIF system and procedure – with its less complicated, simpler approach to treating complex spinal pathologies – is poised to change the way spine care is delivered. Camber Spine now has 20 products with 510(k) clearances and over 28 active or issued patents, including two award-winning, highly innovative and IP protected device platforms that support faster spinal fusion and recovery: ENZA® (MIS Integrated Interbody) spinal fusion implants; and SPIRA® OA (Open Architecture 3D printed) spinal fusion and orthopedic implants. Our 27,000 sq. ft. state-of-the-art facility just outside Philadelphia features meeting facilities, office spaces, a mechanical test lab with full prototype shop and an expanded double cadaver lab.